Janssen-Cilag International NV announced that the European Commission (EC) has granted conditional approval to DARZALEX® (daratumumab) for monotherapy of adult ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE